Please login to the form below

Not currently logged in
Email:
Password:

Ipsen reveals new strategy

Ipsen has published a comprehensive review of its future corporate strategy

Ipsen has unveiled its latest business strategy, which will see it invest in research and grow its operations in the US.

Marc de Garidel, chairman and chief executive of Ipsen, said: "Our strategy is threefold: first, increase focus through the creation of a new franchise-based organisation and increase R&D specialisation on two innovative and differentiated technological platforms, peptides and toxins. Second, within areas of focus, increase significant investments to enhance our research and commercial competitiveness.

"Last, leverage our international footprint, particularly in the USA and in the pharmerging markets, to gain global market share. We thus aspire at more than doubling our 2010 revenues and tripling our 2010 EBIT by 2020."

The company revealed that it expects to record one-off pre-tax costs of up to €100m in 2011 and 2012 related to the transfer of the US commercial operations to the East Coast, the closure of the Barcelona R&D site and other one-off costs related to the implementation of the strategy and of the new organisation.

9th June 2011

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics